Perturbations of the NF-κB pathway are prevalent in hematological malignancies, particularly B-cell lymphomas and multiple myeloma, but also drive many solid tumors (breast, liver, lung, prostate, and others) [10]. The gene discussed is NFKB1; the disease is plasma cell myeloma.